Dr. Thomas Galloway, MD
Claim this profileFox Chase Cancer Center
Studies Squamous Cell Carcinoma
Studies Cancer
9 reported clinical trials
15 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 negative
Stage III
p16 positive
2Cancer
p16 negative
Stage III
p16 positive
Affiliated Hospitals
Clinical Trials Thomas Galloway, MD is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about Thomas Galloway, MD
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Thomas Galloway, MD has experience with
- Cisplatin
- Pembrolizumab
- Intensity-Modulated Radiation Therapy
- Radiation Therapy
- Cemiplimab
- Radiotherapy
Breakdown of trials Thomas Galloway, MD has run
Squamous Cell Carcinoma
Cancer
Oropharyngeal Carcinoma
Laryngeal Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Galloway, MD specialize in?
Thomas Galloway, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 negative patients, or patients who are Stage III.
Is Thomas Galloway, MD currently recruiting for clinical trials?
Yes, Thomas Galloway, MD is currently recruiting for 7 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Thomas Galloway, MD has studied deeply?
Yes, Thomas Galloway, MD has studied treatments such as Cisplatin, Pembrolizumab, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Thomas Galloway, MD?
Apply for one of the trials that Thomas Galloway, MD is conducting.
What is the office address of Thomas Galloway, MD?
The office of Thomas Galloway, MD is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.